• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Epidermal growth factor receptor inhibition induces trichomegaly.

作者信息

Dueland Svein, Sauer Torill, Lund-Johansen Fridtjof, Ostenstad Bjørn, Tveit Kjell Magne

机构信息

Department of Oncology, Ullevaal University Hospital, Oslo, Norway.

出版信息

Acta Oncol. 2003;42(4):345-6. doi: 10.1080/02841860310006038.

DOI:10.1080/02841860310006038
PMID:12899508
Abstract
摘要

相似文献

1
Epidermal growth factor receptor inhibition induces trichomegaly.表皮生长因子受体抑制可诱导毛发增大。
Acta Oncol. 2003;42(4):345-6. doi: 10.1080/02841860310006038.
2
Recent data with anti-epidermal growth factor receptor antibodies and irinotecan in colon cancer.近期关于抗表皮生长因子受体抗体与伊立替康用于结肠癌治疗的数据。
Clin Colorectal Cancer. 2005 Nov;5 Suppl 2:S81-8. doi: 10.3816/ccc.2005.s.011.
3
Successful and well-tolerated second line therapy with cetuximab, irinotecan, and raltitrexed in progressive liver disease due to metastatic colon cancer.西妥昔单抗、伊立替康和雷替曲塞用于转移性结肠癌所致进行性肝病的二线治疗成功且耐受性良好。
J Gastrointest Cancer. 2008;39(1-4):26-8. doi: 10.1007/s12029-009-9060-4. Epub 2009 May 6.
4
Anti-EGFR (cetuximab) combined with irinotecan for treatment of elderly patients with metastatic colorectal cancer (mCRC).西妥昔单抗联合伊立替康治疗老年转移性结直肠癌（mCRC）患者。
J Cancer Res Clin Oncol. 2012 Sep;138(9):1487-92. doi: 10.1007/s00432-012-1229-8. Epub 2012 Apr 22.
5
[Contribution to acneiform eruptions by epidermal growth factor receptor inhibitors].[表皮生长因子受体抑制剂对痤疮样皮疹的影响]
Actas Dermosifiliogr. 2006 Mar;97(2):148-9. doi: 10.1016/s0001-7310(06)73371-3.
6
[Panitumumab-induced trichomegaly].帕尼单抗诱发的睫毛粗长症
Med Clin (Barc). 2013 Apr 20;140(8):e15. doi: 10.1016/j.medcli.2013.01.006. Epub 2013 Mar 11.
7
Highlights from: 42nd Annual Meeting of the American Society of Clinical Oncology.
Clin Colorectal Cancer. 2006 Sep;6(3):184-8. doi: 10.1016/s1533-0028(11)70280-8.
8
Can cetuximab affect paraneoplastic myopathy?西妥昔单抗会影响副肿瘤性肌病吗？
J Neurooncol. 2009 Jul;93(3):437-8. doi: 10.1007/s11060-009-9795-6. Epub 2009 Jan 22.
9
[Efficacy of cetuximab combined with chemotherapy for patients with advanced colorectal cancer and unclear K-ras status].西妥昔单抗联合化疗治疗K-ras状态不明的晚期结直肠癌患者的疗效
Zhonghua Zhong Liu Za Zhi. 2010 Oct;32(10):777-81.
10
Reversible grade 4 hyperbilirubinemia in a patient with UGT1A1 7/7 genotype treated with irinotecan and cetuximab.一名携带UGT1A1 7/7基因型的患者在接受伊立替康和西妥昔单抗治疗后出现可逆性4级高胆红素血症。
Clin Colorectal Cancer. 2007 Mar;6(6):447-9. doi: 10.3816/CCC.2007.n.015.

引用本文的文献

1
iTRAQ-based quantitative proteomics revealing the therapeutic mechanism of a medicinal and edible formula YH0618 in reducing doxorubicin-induced alopecia by targeting keratins and TGF-β/Smad3 pathway.基于iTRAQ的定量蛋白质组学揭示药食两用配方YH0618通过靶向角蛋白和TGF-β/Smad3信号通路减轻阿霉素诱导脱发的治疗机制。
Heliyon. 2024 Jun 18;10(12):e33051. doi: 10.1016/j.heliyon.2024.e33051. eCollection 2024 Jun 30.
2
Retrospective Analysis of Skin Toxicity in Patients under Anti-EGFR Tyrosine Kinase Inhibitors: Our Experience in Lung Cancer.抗表皮生长因子受体酪氨酸激酶抑制剂治疗患者皮肤毒性的回顾性分析：我们在肺癌治疗中的经验
Open Access Maced J Med Sci. 2019 Mar 27;7(6):973-977. doi: 10.3889/oamjms.2019.170. eCollection 2019 Mar 30.
3
The eyelash follicle features and anomalies: A review.睫毛毛囊的特征与异常：综述
J Optom. 2018 Oct-Dec;11(4):211-222. doi: 10.1016/j.optom.2018.05.003. Epub 2018 Jul 17.
4
Hair disorders in patients with cancer.癌症患者的毛发疾病。
J Am Acad Dermatol. 2019 May;80(5):1179-1196. doi: 10.1016/j.jaad.2018.03.055. Epub 2018 Apr 14.
5
Cutaneous complications of molecular targeted therapy used in oncology.肿瘤学中分子靶向治疗的皮肤并发症
J Med Life. 2016 Jan-Mar;9(1):19-25.
6
Eyelash Trichomegaly.
Indian J Dermatol. 2015 Jul-Aug;60(4):378-80. doi: 10.4103/0019-5154.160484.
7
Epidermal growth factor receptor inhibitors related trichomegaly of Eyelashes.表皮生长因子受体抑制剂相关的睫毛粗长症
Oxf Med Case Reports. 2014 Aug 5;2014(5):98-9. doi: 10.1093/omcr/omu038. eCollection 2014 Aug.
8
Dermatological Side Effects of Epidermal Growth Factor Receptor Inhibitors: 'PRIDE' Complex.表皮生长因子受体抑制剂的皮肤副作用：“PRIDE”综合征
Indian J Dermatol. 2014 May;59(3):271-4. doi: 10.4103/0019-5154.131398.
9
A case of acquired trichomegaly following treatment with erlotinib.一例厄洛替尼治疗后获得性睫毛过长症病例。
BMJ Case Rep. 2009;2009. doi: 10.1136/bcr.01.2009.1473. Epub 2009 May 20.
10
Gefitinib-induced hair alterations.吉非替尼引起的毛发改变。
BMJ Case Rep. 2009;2009. doi: 10.1136/bcr.09.2008.0878. Epub 2009 Mar 17.